Principal And Founder
CurrentLobbying firm and consulting specializing drug policy advocacy and helping businesses navigate the ever-changing landscape of state and federal cannabis (marijuana) laws and regulations.• Collaborated with House Judiciary Chairman Nadler’s staff as a member of the Marijuana Justice Coalition on drafting the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, and the successful whip operation with Congressman Blumenauer and Congresswoman Lee’s teams to pass the bill • Represented the Multidisciplinary Association for Psychedelic Studies to reduce barriers to studying Schedule I substances to treat conditions such as post-traumatic stress disorder and depression • Pro-bono policy advisor and mentor to policy interns at Students for Sensible Drug Policy• Led the Drug Policy Alliance’s federal cannabis lobbying efforts from August 2017 through June 2018, working with Senators Warren, Schumer, and Gardener’s offices on the drafting of the STATES Act and Marijuana Freedom and Opportunity Act in the 115th Congress• Drafted questions posed to then-Attorney General Sessions for Senator Leahy when examining the AG’s cannabis policy during a November 2017 Senate Judiciary Committee oversight hearing• Co-authored 2017 State Cannabis Laws report the National Cannabis Business Industry Association• Researched and wrote state cannabis business license applications, obtaining licensure in MD, MA, and OH